How do you take ashwagandha?

Doses and schedules in trials and on labels
TrialDose, schedule and lengthPeople
Chandrasekhar3300 mg of high-concentration full-spectrum root extract per capsule, one capsule twice a day, for 60 days, or placebo64 stressed adults
Salve (stress, two doses)4Twice daily for eight weeks, after food with milk or water: capsules of 125 mg (250 mg/day) or 300 mg (600 mg/day), or identical placeboSixty enrolled, 58 completed
Choudhary 2016 (chronic stress)1300 mg of KSM-66 root extract standardized to 5% withanolides, in capsule form, twice daily with water for 8 weeks, or placebo52 adults aged 18 to 60
Wankhede (strength)5300 mg KSM-66 capsule twice a day, after waking and before bed, for 8 weeks, or 300 mg starch capsules57 recruited, 50 completed
Choudhary (endurance)6One 300 mg KSM-66 capsule orally, twice daily for 12 weeks, or identical sucrose capsules50 healthy athletic adults
Lopresti (crossover)7Two 300 mg tablets once daily, 2 hours away from food (preferably after dinner); 600 mg extract daily, delivering 21 mg withanolide glycosides, for 8 weeks, with placebo for the other 8 weeks of a 16-week crossover with no washoutOverweight men aged 40–70
Salve (12-month observational study, no placebo)8Prescribed 600 mg/day, for 12 months: 300 mg per capsule (12:1 drug-to-extract ratio), twice daily after meals with water191 adults aged 18–65

In a 2016 trial of 52 adults under chronic stress (Choudhary), 300 mg of KSM-66 root extract was taken in capsule form twice daily with water for 8 weeks, and a US product label gives 1 capsule 1 to 2 times per day with water, or as directed by a qualified healthcare professional.12

Doses and schedules in trials and on labels

The table is set at the top of the page

Product labels and regulators

On one product label a capsule holds 300 mg of KSM-66 root extract.2 A second label states 1,000 mg ashwagandha per daily serving, a blend of 600 mg KSM-66 root extract and 400 mg root powder, and lists two capsules daily with water for adults; its warnings mention pregnant or nursing women and that it is not intended for persons under 18.9 No drug label or regulator dose for ashwagandha alone turned up in DailyMed, the EMA statement or NCCIH. The EMA's herbal committee (HMPC) could not establish a Community herbal monograph for the root, as it found no adequate evidence of at least 30 years of medicinal use including at least 15 years in the European Union, and insufficient extract specification to describe the herbal preparations.10

Higher doses and extract strength

The search found no human trial at the much higher doses people ask about. A single-dose crossover in 16 healthy volunteers compared two extracts, one standardized to 35% withanolide glycosides and one to 2.5% withanolides, matched at 185 mg of total withanolides each, with a washout of at least 7 days between them.11

Storage

Subjects in the Wankhede trial were told to store the capsules at 18 to 32 °C.5 One product label says to store in a cool and dry place after opening.9 The searches returned nothing on storage of powder or mixed preparations.

Frequently asked questions

Do you need to cycle ashwagandha?

Searches of PubMed, NCCIH and the trial registry found nothing on cycling or an off period. NCCIH says ashwagandha may be safe in the short term (up to 3 months) and that long-term safety information is lacking.12 The longest use among the studies above was 12 months, in an observational study without a placebo group that enrolled 191 adults aged 18–65 (Salve).8

How do you mix ashwagandha powder?

Searches found no usable maker leaflet on which liquid to use or how much. The milk and water in the trials above went with capsules, not powder.

Is ashwagandha safe in pregnancy or for the liver?

NCCIH advises avoiding ashwagandha during pregnancy and not using it while breastfeeding, and notes that, although it is rare, a number of cases link liver injury to ashwagandha supplements.12 A case series of five liver injury cases attributed to ashwagandha-containing supplements, three from Iceland and two from the US Drug-Induced Liver Injury Network, reports that in the three Icelandic cases the daily dose varied from 450 to 1350 mg.13

References

  1. PubMed Central. Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial. pmc.ncbi.nlm.nih.gov
  2. NIH DSLD product label. Supplement Facts. api.ods.od.nih.gov
  3. PubMed Central. A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of a High-Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults. 2012. pmc.ncbi.nlm.nih.gov
  4. PubMed Central. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. 2019. pmc.ncbi.nlm.nih.gov
  5. PubMed Central. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. 2015. pmc.ncbi.nlm.nih.gov
  6. PubMed Central. Efficacy of Ashwagandha ( Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults. 2015. pmc.ncbi.nlm.nih.gov
  7. PubMed Central. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera ) in Aging, Overweight Males. 2019. pmc.ncbi.nlm.nih.gov
  8. PubMed Central. Safety of 12‐Months Administration of Ashwagandha ( Withania somnifera ) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study. 2025. pmc.ncbi.nlm.nih.gov
  9. NIH DSLD product label. Ashwagandha Costco_150ct_06.12.20_bold. api.ods.od.nih.gov
  10. EMA HMPC. Public statement on Withania somnifera (L.) Dunal, radix. ema.europa.eu
  11. PubMed Central. Pharmacokinetics and bioequivalence of Withania somnifera (Ashwagandha) extracts – A double blind, crossover study in healthy adults. 2023. pmc.ncbi.nlm.nih.gov
  12. NCCIH. Ashwagandha: Usefulness and Safety. nccih.nih.gov
  13. PubMed Central. Liver Injury due to Ashwagandha. A Case Series from Iceland and the U.S. Drug-Induced Liver Injury Network. 2020. pmc.ncbi.nlm.nih.gov